Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global FIS1 Antibody Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global FIS1 Antibody Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global FIS1 Antibody Market Perspective (2018-2033)
2.2 FIS1 Antibody Growth Trends by Region
2.2.1 Global FIS1 Antibody Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 FIS1 Antibody Historic Market Size by Region (2018-2023)
2.2.3 FIS1 Antibody Forecasted Market Size by Region (2024-2033)
2.3 FIS1 Antibody Market Dynamics
2.3.1 FIS1 Antibody Industry Trends
2.3.2 FIS1 Antibody Market Drivers
2.3.3 FIS1 Antibody Market Challenges
2.3.4 FIS1 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top FIS1 Antibody Players by Revenue
3.1.1 Global Top FIS1 Antibody Players by Revenue (2018-2023)
3.1.2 Global FIS1 Antibody Revenue Market Share by Players (2018-2023)
3.2 Global FIS1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by FIS1 Antibody Revenue
3.4 Global FIS1 Antibody Market Concentration Ratio
3.4.1 Global FIS1 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by FIS1 Antibody Revenue in 2022
3.5 FIS1 Antibody Key Players Head office and Area Served
3.6 Key Players FIS1 Antibody Product Solution and Service
3.7 Date of Enter into FIS1 Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 FIS1 Antibody Breakdown Data by Type
4.1 Global FIS1 Antibody Historic Market Size by Type (2018-2023)
4.2 Global FIS1 Antibody Forecasted Market Size by Type (2024-2033)
5 FIS1 Antibody Breakdown Data by Application
5.1 Global FIS1 Antibody Historic Market Size by Application (2018-2023)
5.2 Global FIS1 Antibody Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America FIS1 Antibody Market Size (2018-2033)
6.2 North America FIS1 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America FIS1 Antibody Market Size by Country (2018-2023)
6.4 North America FIS1 Antibody Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe FIS1 Antibody Market Size (2018-2033)
7.2 Europe FIS1 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe FIS1 Antibody Market Size by Country (2018-2023)
7.4 Europe FIS1 Antibody Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific FIS1 Antibody Market Size (2018-2033)
8.2 Asia-Pacific FIS1 Antibody Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific FIS1 Antibody Market Size by Region (2018-2023)
8.4 Asia-Pacific FIS1 Antibody Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America FIS1 Antibody Market Size (2018-2033)
9.2 Latin America FIS1 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America FIS1 Antibody Market Size by Country (2018-2023)
9.4 Latin America FIS1 Antibody Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa FIS1 Antibody Market Size (2018-2033)
10.2 Middle East & Africa FIS1 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa FIS1 Antibody Market Size by Country (2018-2023)
10.4 Middle East & Africa FIS1 Antibody Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck FIS1 Antibody Introduction
11.1.4 Merck Revenue in FIS1 Antibody Business (2018-2023)
11.1.5 Merck Recent Development
11.2 Bioss
11.2.1 Bioss Company Detail
11.2.2 Bioss Business Overview
11.2.3 Bioss FIS1 Antibody Introduction
11.2.4 Bioss Revenue in FIS1 Antibody Business (2018-2023)
11.2.5 Bioss Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific FIS1 Antibody Introduction
11.3.4 Thermo Fisher Scientific Revenue in FIS1 Antibody Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Novus Biologicals
11.4.1 Novus Biologicals Company Detail
11.4.2 Novus Biologicals Business Overview
11.4.3 Novus Biologicals FIS1 Antibody Introduction
11.4.4 Novus Biologicals Revenue in FIS1 Antibody Business (2018-2023)
11.4.5 Novus Biologicals Recent Development
11.5 GeneTex
11.5.1 GeneTex Company Detail
11.5.2 GeneTex Business Overview
11.5.3 GeneTex FIS1 Antibody Introduction
11.5.4 GeneTex Revenue in FIS1 Antibody Business (2018-2023)
11.5.5 GeneTex Recent Development
11.6 Enzo Life Sciences, Inc.
11.6.1 Enzo Life Sciences, Inc. Company Detail
11.6.2 Enzo Life Sciences, Inc. Business Overview
11.6.3 Enzo Life Sciences, Inc. FIS1 Antibody Introduction
11.6.4 Enzo Life Sciences, Inc. Revenue in FIS1 Antibody Business (2018-2023)
11.6.5 Enzo Life Sciences, Inc. Recent Development
11.7 RayBiotech
11.7.1 RayBiotech Company Detail
11.7.2 RayBiotech Business Overview
11.7.3 RayBiotech FIS1 Antibody Introduction
11.7.4 RayBiotech Revenue in FIS1 Antibody Business (2018-2023)
11.7.5 RayBiotech Recent Development
11.8 LifeSpan BioSciences
11.8.1 LifeSpan BioSciences Company Detail
11.8.2 LifeSpan BioSciences Business Overview
11.8.3 LifeSpan BioSciences FIS1 Antibody Introduction
11.8.4 LifeSpan BioSciences Revenue in FIS1 Antibody Business (2018-2023)
11.8.5 LifeSpan BioSciences Recent Development
11.9 Leading Biology
11.9.1 Leading Biology Company Detail
11.9.2 Leading Biology Business Overview
11.9.3 Leading Biology FIS1 Antibody Introduction
11.9.4 Leading Biology Revenue in FIS1 Antibody Business (2018-2023)
11.9.5 Leading Biology Recent Development
11.10 ProSci
11.10.1 ProSci Company Detail
11.10.2 ProSci Business Overview
11.10.3 ProSci FIS1 Antibody Introduction
11.10.4 ProSci Revenue in FIS1 Antibody Business (2018-2023)
11.10.5 ProSci Recent Development
11.11 Abcam
11.11.1 Abcam Company Detail
11.11.2 Abcam Business Overview
11.11.3 Abcam FIS1 Antibody Introduction
11.11.4 Abcam Revenue in FIS1 Antibody Business (2018-2023)
11.11.5 Abcam Recent Development
11.12 OriGene Technologies
11.12.1 OriGene Technologies Company Detail
11.12.2 OriGene Technologies Business Overview
11.12.3 OriGene Technologies FIS1 Antibody Introduction
11.12.4 OriGene Technologies Revenue in FIS1 Antibody Business (2018-2023)
11.12.5 OriGene Technologies Recent Development
11.13 NSJ Bioreagents
11.13.1 NSJ Bioreagents Company Detail
11.13.2 NSJ Bioreagents Business Overview
11.13.3 NSJ Bioreagents FIS1 Antibody Introduction
11.13.4 NSJ Bioreagents Revenue in FIS1 Antibody Business (2018-2023)
11.13.5 NSJ Bioreagents Recent Development
11.14 Affinity Biosciences
11.14.1 Affinity Biosciences Company Detail
11.14.2 Affinity Biosciences Business Overview
11.14.3 Affinity Biosciences FIS1 Antibody Introduction
11.14.4 Affinity Biosciences Revenue in FIS1 Antibody Business (2018-2023)
11.14.5 Affinity Biosciences Recent Development
11.15 Biobyt
11.15.1 Biobyt Company Detail
11.15.2 Biobyt Business Overview
11.15.3 Biobyt FIS1 Antibody Introduction
11.15.4 Biobyt Revenue in FIS1 Antibody Business (2018-2023)
11.15.5 Biobyt Recent Development
11.16 Jingjie PTM BioLab
11.16.1 Jingjie PTM BioLab Company Detail
11.16.2 Jingjie PTM BioLab Business Overview
11.16.3 Jingjie PTM BioLab FIS1 Antibody Introduction
11.16.4 Jingjie PTM BioLab Revenue in FIS1 Antibody Business (2018-2023)
11.16.5 Jingjie PTM BioLab Recent Development
11.17 Beijing Solarbio
11.17.1 Beijing Solarbio Company Detail
11.17.2 Beijing Solarbio Business Overview
11.17.3 Beijing Solarbio FIS1 Antibody Introduction
11.17.4 Beijing Solarbio Revenue in FIS1 Antibody Business (2018-2023)
11.17.5 Beijing Solarbio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global FIS1 Antibody Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global FIS1 Antibody Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global FIS1 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global FIS1 Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global FIS1 Antibody Market Share by Region (2018-2023)
Table 8. Global FIS1 Antibody Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global FIS1 Antibody Market Share by Region (2024-2033)
Table 10. FIS1 Antibody Market Trends
Table 11. FIS1 Antibody Market Drivers
Table 12. FIS1 Antibody Market Challenges
Table 13. FIS1 Antibody Market Restraints
Table 14. Global FIS1 Antibody Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global FIS1 Antibody Market Share by Players (2018-2023)
Table 16. Global Top FIS1 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in FIS1 Antibody as of 2022)
Table 17. Ranking of Global Top FIS1 Antibody Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by FIS1 Antibody Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players FIS1 Antibody Product Solution and Service
Table 21. Date of Enter into FIS1 Antibody Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global FIS1 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global FIS1 Antibody Revenue Market Share by Type (2018-2023)
Table 25. Global FIS1 Antibody Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global FIS1 Antibody Revenue Market Share by Type (2024-2033)
Table 27. Global FIS1 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global FIS1 Antibody Revenue Market Share by Application (2018-2023)
Table 29. Global FIS1 Antibody Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global FIS1 Antibody Revenue Market Share by Application (2024-2033)
Table 31. North America FIS1 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America FIS1 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America FIS1 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe FIS1 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe FIS1 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe FIS1 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific FIS1 Antibody Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific FIS1 Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific FIS1 Antibody Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America FIS1 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America FIS1 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America FIS1 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa FIS1 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa FIS1 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa FIS1 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck FIS1 Antibody Product
Table 49. Merck Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Bioss Company Detail
Table 52. Bioss Business Overview
Table 53. Bioss FIS1 Antibody Product
Table 54. Bioss Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 55. Bioss Recent Development
Table 56. Thermo Fisher Scientific Company Detail
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific FIS1 Antibody Product
Table 59. Thermo Fisher Scientific Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Novus Biologicals Company Detail
Table 62. Novus Biologicals Business Overview
Table 63. Novus Biologicals FIS1 Antibody Product
Table 64. Novus Biologicals Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 65. Novus Biologicals Recent Development
Table 66. GeneTex Company Detail
Table 67. GeneTex Business Overview
Table 68. GeneTex FIS1 Antibody Product
Table 69. GeneTex Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 70. GeneTex Recent Development
Table 71. Enzo Life Sciences, Inc. Company Detail
Table 72. Enzo Life Sciences, Inc. Business Overview
Table 73. Enzo Life Sciences, Inc. FIS1 Antibody Product
Table 74. Enzo Life Sciences, Inc. Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 75. Enzo Life Sciences, Inc. Recent Development
Table 76. RayBiotech Company Detail
Table 77. RayBiotech Business Overview
Table 78. RayBiotech FIS1 Antibody Product
Table 79. RayBiotech Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 80. RayBiotech Recent Development
Table 81. LifeSpan BioSciences Company Detail
Table 82. LifeSpan BioSciences Business Overview
Table 83. LifeSpan BioSciences FIS1 Antibody Product
Table 84. LifeSpan BioSciences Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 85. LifeSpan BioSciences Recent Development
Table 86. Leading Biology Company Detail
Table 87. Leading Biology Business Overview
Table 88. Leading Biology FIS1 Antibody Product
Table 89. Leading Biology Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 90. Leading Biology Recent Development
Table 91. ProSci Company Detail
Table 92. ProSci Business Overview
Table 93. ProSci FIS1 Antibody Product
Table 94. ProSci Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 95. ProSci Recent Development
Table 96. Abcam Company Detail
Table 97. Abcam Business Overview
Table 98. Abcam FIS1 Antibody Product
Table 99. Abcam Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 100. Abcam Recent Development
Table 101. OriGene Technologies Company Detail
Table 102. OriGene Technologies Business Overview
Table 103. OriGene Technologies FIS1 Antibody Product
Table 104. OriGene Technologies Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 105. OriGene Technologies Recent Development
Table 106. NSJ Bioreagents Company Detail
Table 107. NSJ Bioreagents Business Overview
Table 108. NSJ Bioreagents FIS1 Antibody Product
Table 109. NSJ Bioreagents Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 110. NSJ Bioreagents Recent Development
Table 111. Affinity Biosciences Company Detail
Table 112. Affinity Biosciences Business Overview
Table 113. Affinity Biosciences FIS1 Antibody Product
Table 114. Affinity Biosciences Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 115. Affinity Biosciences Recent Development
Table 116. Biobyt Company Detail
Table 117. Biobyt Business Overview
Table 118. Biobyt FIS1 Antibody Product
Table 119. Biobyt Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 120. Biobyt Recent Development
Table 121. Jingjie PTM BioLab Company Detail
Table 122. Jingjie PTM BioLab Business Overview
Table 123. Jingjie PTM BioLab FIS1 Antibody Product
Table 124. Jingjie PTM BioLab Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 125. Jingjie PTM BioLab Recent Development
Table 126. Beijing Solarbio Company Detail
Table 127. Beijing Solarbio Business Overview
Table 128. Beijing Solarbio FIS1 Antibody Product
Table 129. Beijing Solarbio Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 130. Beijing Solarbio Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global FIS1 Antibody Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global FIS1 Antibody Market Share by Type: 2022 VS 2033
Figure 3. Monoclonal Features
Figure 4. Polyclonal Features
Figure 5. Global FIS1 Antibody Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global FIS1 Antibody Market Share by Application: 2022 VS 2033
Figure 7. Immunochemistry (IHC) Case Studies
Figure 8. Immunofluorescence (IF) Case Studies
Figure 9. Immunoprecipitation (IP) Case Studies
Figure 10. Western Blot (WB) Case Studies
Figure 11. ELISA Case Studies
Figure 12. Others Case Studies
Figure 13. FIS1 Antibody Report Years Considered
Figure 14. Global FIS1 Antibody Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global FIS1 Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global FIS1 Antibody Market Share by Region: 2022 VS 2033
Figure 17. Global FIS1 Antibody Market Share by Players in 2022
Figure 18. Global Top FIS1 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in FIS1 Antibody as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by FIS1 Antibody Revenue in 2022
Figure 20. North America FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America FIS1 Antibody Market Share by Country (2018-2033)
Figure 22. United States FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe FIS1 Antibody Market Share by Country (2018-2033)
Figure 26. Germany FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific FIS1 Antibody Market Share by Region (2018-2033)
Figure 34. China FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America FIS1 Antibody Market Share by Country (2018-2033)
Figure 42. Mexico FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa FIS1 Antibody Market Share by Country (2018-2033)
Figure 46. Turkey FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Merck Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 49. Bioss Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 51. Novus Biologicals Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 52. GeneTex Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 53. Enzo Life Sciences, Inc. Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 54. RayBiotech Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 55. LifeSpan BioSciences Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 56. Leading Biology Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 57. ProSci Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 58. Abcam Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 59. OriGene Technologies Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 60. NSJ Bioreagents Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 61. Affinity Biosciences Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 62. Biobyt Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 63. Jingjie PTM BioLab Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 64. Beijing Solarbio Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed